Download Free Sample Report

The global Prostate Cancer Screening market was valued at US$ 13820 million in 2022 and is projected to reach US$ 22650 million by 2029, at a CAGR of 7.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Screening. This report contains market size and forecasts of Prostate Cancer Screening in global, including the following market information:
Global Prostate Cancer Screening Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The digital rectal examination is one screening tool during which the prostate is assessed manually through the wall of the rectum. The second screening tool is the measurement of prostate-specific antigen in the blood.
We surveyed the Prostate Cancer Screening companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:

• Physical Exam
• Laboratory Tests
• Imaging Tests
• Gleason Score
• TNM Score
• Genetic Tests
• Digital Rectal Exam
• Biopsy

• Hospitals
• Clinics
• Research Labs
• Cancer Institutes
• Diagnostic Centers
• Others

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

• Key companies Prostate Cancer Screening revenues in global market, 2018-2023 (estimated), ($ millions)
• Key companies Prostate Cancer Screening revenues share in global market, 2022 (%)

• Abbott Laboratories
• Almac
• Bayer
• Beckman Coulter
• BiomRieux
• Genomic Health
• Mayo Clinic
• Mdxhealth
• Roche Diagnostics
• Rosetta Genomics
• Thermo Fisher Scientific
• Hologic
• Myriad Genetics

Chapter 1: Introduces the definition of Prostate Cancer Screening, market overview.
Chapter 2: Global Prostate Cancer Screening market size in revenue.
Chapter 3: Detailed analysis of Prostate Cancer Screening company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prostate Cancer Screening in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.